D
Deborah Donnell
Researcher at Fred Hutchinson Cancer Research Center
Publications - 231
Citations - 13344
Deborah Donnell is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Pre-exposure prophylaxis & Population. The author has an hindex of 49, co-authored 199 publications receiving 11097 citations. Previous affiliations of Deborah Donnell include University of California, Los Angeles & University of Washington.
Papers
More filters
Journal ArticleDOI
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial
Nelly Mugo,Nelly Mugo,Randy M. Stalter,Renee Heffron,Helen Rees,Caitlin W Scoville,Charles S. Morrison,Athena P. Kourtis,Elizabeth A. Bukusi,Malgorzata E. Beksinska,Neena M. Philip,Ivana Beesham,Jen Deese,Vinodh Edward,Deborah Donnell,Jared M. Baeten +15 more
TL;DR: In a randomized trial of the effect of three contraceptive methods – DMPA-IM, a copper intrauterine device (IUD), and a levonorgestrel (LNG) implant – on HIV acquisition, HSV-2 acquisition was not associated with increased risk of HSV -2 acquisition and incidence was >10% per year, emphasizing the need for development of novel HSv-2 prevention strategies for African women.
Journal ArticleDOI
Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052
Sahar Z Zangeneh,Ethan Wilson,Surabhi Ahluwalia,Deborah Donnell,Ying Q. Chen,Beatriz Grinsztejn,Marineide Gonçalves de Melo,Sheela Godbole,Mina C. Hosseinipour,Taha Salah Taha,Johnstone Kumwenda,Marybeth McCauley,Myron S. Cohen,Karin Nielsen-Saines +13 more
TL;DR: The HPTN 052 clinical trial as discussed by the authors explored associations between pregnancy and clinical measures of HIV disease stage and progression, and concluded that becoming pregnant does not pose a threat to maternal health in women with HIV when there is access to medical care and antiretroviral treatment.
Journal ArticleDOI
HIV drug resistance in a community‐randomized trial of universal testing and treatment: HPTN 071 (PopART)
Jessica M. Fogel,Ethan Wilson,Estelle Piwowar-Manning,Autumn Breaud,William Clarke,Christos J. Petropoulos,Ayana Moore,Christophe Fraser,Barry R. Kosloff,Kwame Shanaube,Gert U. van Zyl,Michelle Scheepers,Sian Floyd,Peter Bock,Helen Ayles,Sarah Fidler,Richard J. Hayes,Deborah Donnell,Susan H. Eshleman +18 more
TL;DR: The impact of UTT on HIV drug resistance in this cohort was evaluated and other resistance‐related outcomes in participants with recent versus non‐recent HIV infection were compared.
Reversibility of kidney function decline in HIV-1–uninfected men and women using preexposure prophylaxis
Allan Ronald,Christina M. Wyatt,Nelly Mugo,Kenneth K Mugwanya,Deborah Donnell,James Kiarie,Jared Baeten,Connie Celum +7 more
Journal ArticleDOI
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial
Ethan Wilson,Deborah Donnell,Timothy Michael Skalland,Sian Floyd,Ayana Moore,Nomtha Bell-Mandla,Justin Bwalya,Nkatya Kasese,Rory Dunbar,Kwame Shanaube,Barry R. Kosloff,Oliver Laeyendecker,Yaw Agyei,Graeme Hoddinott,Peter Bock,Sarah Fidler,Richard J. Hayes,Helen Ayles +17 more